Literature DB >> 9688062

Development of a new quantitative approach for the isobolographic assessment of the convulsant interaction between pefloxacin and theophylline in rats.

L M Levasseur1, A Delon, W R Greco, P Faury, S Bouquet, W Couet.   

Abstract

PURPOSE: A new mathematical approach was developed to quantify convulsant interaction between pefloxacin and theophylline in rats.
METHODS: Animals received each compound separately or in different combination ratios. Infusion was stopped at the onset of maximal seizures. Cerebrospinal fluid (CSF) and plasma samples were collected for HPLC drug determination. The nature and intensity of the pharmacodynamic (PD) interaction between drugs was assessed with a new modeling approach which includes (a) data transformation to create an essentially error-free X-variable and (b) estimation of an interaction parameter a by fitting a nonlinear hyperbolic model to the combination data with unweighted nonlinear regression.
RESULTS: Drug disposition to the biophase was linear within the range of administered doses. The estimates of a suggested a Loewe antagonistic interaction between pefloxacin and theophylline at the induction of maximal seizures in rats. Similar intensity of PD interaction was observed at the dose and biophase level (alpha was -0.415 +/- 0.069 and -0.567 +/- 0.079, respectively).
CONCLUSIONS: The suitability of the proposed model was assessed by Monte Carlo simulation. This new mathematical approach enabled the characterization of the Loewe antagonistic nature of the PD (convulsant) interaction between pefloxacin and theophylline, whereas previously used methodologies failed to do so.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9688062     DOI: 10.1023/a:1011938429379

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  9 in total

1.  Isobolographic assessment of the convulsant interaction between theophylline and caffeine or pentylenetetrazol in rats.

Authors:  J G Zhi; G Levy
Journal:  J Pharm Sci       Date:  1990-08       Impact factor: 3.534

Review 2.  Synergy, additivism and antagonism in immunosuppression. A critical review.

Authors:  M C Berenbaum
Journal:  Clin Exp Immunol       Date:  1977-04       Impact factor: 4.330

Review 3.  Pharmacokinetic interactions between theophylline and other medication (Part I).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-01       Impact factor: 6.447

Review 4.  The search for synergy: a critical review from a response surface perspective.

Authors:  W R Greco; G Bravo; J C Parsons
Journal:  Pharmacol Rev       Date:  1995-06       Impact factor: 25.468

5.  Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in rats.

Authors:  A Delon; F Huguet; P Courtois; J M Vierfond; S Bouquet; W Couet
Journal:  J Pharmacol Exp Ther       Date:  1997-02       Impact factor: 4.030

6.  Cerebrospinal fluid transport and disposition of the quinolones ciprofloxacin and pefloxacin in rats.

Authors:  U Jaehde; M W Langemeijer; A G de Boer; D D Breimer
Journal:  J Pharmacol Exp Ther       Date:  1992-12       Impact factor: 4.030

7.  Kinetics of drug action in disease states. XVI. Pharmacodynamics of theophylline-induced seizures in rats.

Authors:  I M Ramzan; G Levy
Journal:  J Pharmacol Exp Ther       Date:  1986-03       Impact factor: 4.030

8.  Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.

Authors:  S Segev; M Rehavi; E Rubinstein
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

9.  A new approach for early assessment of the epileptogenic potential of quinolones.

Authors:  A Delon; C Pariat; P Courtois; S Bouquet; W Couet
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

  9 in total
  7 in total

1.  Antagonistic interaction between the convulsant activities of pefloxacin and its main metabolite norfloxacin in rats.

Authors:  A Delon; L M Levasseur; M Giraudon; S Bouquet; W Couet
Journal:  Pharm Res       Date:  1999-12       Impact factor: 4.200

2.  Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effect of imipenem in healthy rats.

Authors:  A Dupuis; W Couet; J Paquereau; S Debarre; A Portron; C Jamois; S Bouquet
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

3.  Ignoring pharmacokinetics may lead to isoboles misinterpretation: illustration with the norfloxacin-theophylline convulsant interaction in rats.

Authors:  Miren Cadart; Sandrine Marchand; Claudine Pariat; Serge Bouquet; William Couet
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

4.  Pharmacokinetic-pharmacodynamic modelling of the convulsant interaction between norfloxacin and biphenyl acetic acid in rats.

Authors:  S Marchand; C Pariat; S Bouquet; P Courtois; W Couet
Journal:  Br J Pharmacol       Date:  2000-04       Impact factor: 8.739

5.  Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of fluoroquinolones in rats.

Authors:  A Delon; S Bouquet; F Huguet; V Brunet; P Courtois; W Couet
Journal:  Antimicrob Agents Chemother       Date:  1999-06       Impact factor: 5.191

6.  A new approach for early assessment of the epileptogenic potential of quinolones.

Authors:  A Delon; C Pariat; P Courtois; S Bouquet; W Couet
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191

7.  Analyses of the combination of 6-MP and dasatinib in cell culture.

Authors:  Gurmeet Kaur; Holger Behrsing; Ralph E Parchment; Myrtle Davis Millin; Beverly A Teicher
Journal:  Int J Oncol       Date:  2013-05-02       Impact factor: 5.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.